Prenetics Competitors

PRE Stock  USD 21.12  1.88  9.77%   
Prenetics Global competes with Neuronetics, Atlantic International, MaxCyte, TriSalus Life, and Profound Medical; as well as few others. The company runs under Insurance sector within Financials industry. Analyzing Prenetics Global competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Prenetics Global to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Prenetics Global Correlation with its peers.
For information on how to trade Prenetics Stock refer to our How to Trade Prenetics Stock guide.

Prenetics Global vs Codexis Correlation

Excellent diversification

The correlation between Prenetics Global and CDXS is -0.64 (i.e., Excellent diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Prenetics Global and CDXS in the same portfolio, assuming nothing else is changed.

Moving together with Prenetics Stock

  0.69HG Hamilton Insurance Normal TradingPairCorr

Moving against Prenetics Stock

  0.85SR9A Swiss Re AGPairCorr
  0.84SREN Swiss Re AGPairCorr
  0.81MHNC Maiden Holdings NorthPairCorr
  0.44HNR1 Hannover Rck SEPairCorr
  0.42MUV2 Mnchener Rck AGPairCorr
As of February 10, 2026, Return On Tangible Assets is expected to decline to -0.27. In addition to that, Return On Capital Employed is expected to decline to -0.26. At present, Prenetics Global's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 107.8 M, whereas Other Assets are projected to grow to (7.1 M).
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
16.0121.1126.21
Details
Intrinsic
Valuation
LowRealHigh
18.6423.7428.84
Details
1 Analysts
Consensus
LowTargetHigh
28.2131.0034.41
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.56-0.56-0.56
Details

Prenetics Global Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Prenetics Global and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Prenetics and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Prenetics Global does not affect the price movement of the other competitor.

High positive correlations

CDXSMXCT
OSURATLN
ATLNSTIM
CDXSSGMO
OSURPROF
IMDXSTIM
  

High negative correlations

OSURMXCT
TLSIATLN
MXCTATLN
IMDXTLSI
CDXSARMP
TLSISTIM

Risk-Adjusted Indicators

There is a big difference between Prenetics Stock performing well and Prenetics Global Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Prenetics Global's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
STIM  5.55 (1.07) 0.00 (0.21) 0.00 
 10.55 
 34.69 
ATLN  7.23  0.50  0.09  0.21  7.21 
 20.00 
 64.87 
MXCT  3.17 (1.16) 0.00 (0.59) 0.00 
 5.44 
 15.87 
TLSI  3.37 (0.05)(0.01) 0.03  4.45 
 8.30 
 25.94 
PROF  2.99  0.07  0.04  0.13  3.33 
 7.37 
 19.12 
OSUR  2.46 (0.01) 0.03  0.08  3.07 
 5.98 
 13.45 
IMDX  4.07  0.11  0.06  0.13  4.28 
 9.42 
 22.08 
ARMP  5.34  0.86  0.13  0.74  5.96 
 14.73 
 38.51 
SGMO  4.91 (0.47) 0.00 (0.06) 0.00 
 9.52 
 73.25 
CDXS  3.96 (0.90) 0.00 (0.24) 0.00 
 6.21 
 22.77 

Cross Equities Net Income Analysis

Compare Prenetics Global and related stocks such as Neuronetics, Atlantic International, and MaxCyte Net Income Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Shareholders Equity Per ShareDebt To Equity
Capex Per ShareGraham Net Net
Average ReceivablesRevenue Per Share
Interest Debt Per ShareDebt To Assets
Enterprise Value Over E B I T D AShort Term Coverage Ratios
Price Earnings RatioOperating Cycle
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Cash Conversion CycleOperating Cash Flow Sales Ratio
Days Of Inventory OutstandingDays Of Sales Outstanding
Free Cash Flow Operating Cash Flow RatioCash Flow Coverage Ratios
Price To Book RatioFixed Asset Turnover
Capital Expenditure Coverage RatioPrice Cash Flow Ratio
Enterprise Value MultipleDebt Ratio
Cash Flow To Debt RatioPrice Sales Ratio
Return On AssetsAsset Turnover
Net Profit MarginGross Profit Margin
Price Fair ValueReturn On Equity
20102011201220132014201520162017201820192020202120222023202420252026
STIM(11.2 M)(11.2 M)(11.2 M)(11.2 M)(11.2 M)(11.2 M)(11.2 M)(16.1 M)(24.1 M)(29 M)(27.5 M)(31.2 M)(37.2 M)(30.2 M)(43.7 M)(39.3 M)(41.3 M)
ATLN(1.4 M)(1.4 M)(1.4 M)(1.4 M)(1.4 M)(1.4 M)(1.4 M)(1.7 M)(2.9 M)(2.5 M)(1 M)(40.8 M)(3.2 M)(15.3 M)(135.5 M)(121.9 M)(115.8 M)
MXCT(2 M)(2 M)(2 M)(958.2 K)(1.8 M)(1.4 M)(3.3 M)(9.9 M)(8.9 M)(12.9 M)(11.8 M)(19.1 M)(23.6 M)(37.9 M)(41.1 M)(36.9 M)(35.1 M)
TLSI(28.8 M)(28.8 M)(28.8 M)(28.8 M)(28.8 M)(28.8 M)(28.8 M)(28.8 M)(28.8 M)(28.8 M)(28.8 M)(28.8 M)(47.2 M)(59.4 M)(33.2 M)(29.9 M)(31.4 M)
PROF(8.2 M)(8.2 M)(8.2 M)(8.2 M)(8.2 M)(11.8 M)(12.1 M)(15 M)(15.2 M)(15.2 M)(21.6 M)(30.7 M)(28.7 M)(28.6 M)(26.5 M)(23.8 M)(25 M)
OSUR(2.6 M)(8.8 M)(15.1 M)(11.2 M)(4.6 M)8.2 M19.7 M30.9 M20.4 M16.7 M(14.9 M)(23 M)(17.1 M)53.7 M(19.5 M)(22.4 M)(21.3 M)
IMDX(3.5 M)(3.5 M)(3.5 M)(3.5 M)(5 M)(8.7 M)(11.2 M)(19.4 M)(15.8 M)(22.3 M)(29.9 M)(64.1 M)(72.9 M)(27.8 M)(60.7 M)(54.6 M)(51.9 M)
ARMP(5.1 M)(3.8 M)(1.1 M)(64.6 M)23.1 M(516 K)(18.8 M)(12.8 M)(12.1 M)(19.5 M)(22.2 M)(23.2 M)(36.9 M)(69 M)(18.9 M)(17 M)(17.9 M)
SGMO(308 K)(35.8 M)(22.3 M)(26.6 M)(26.4 M)(40.7 M)(71.7 M)(54.6 M)(68.3 M)(75.8 M)(121.1 M)(178.3 M)(192.3 M)(257.8 M)(97.9 M)(88.1 M)(83.7 M)
CDXS(18.7 M)(16.6 M)(30.9 M)(41.3 M)(19.1 M)(7.6 M)(8.6 M)(23 M)(10.9 M)(11.9 M)(24 M)(21.3 M)(33.6 M)(76.2 M)(65.3 M)(58.7 M)(55.8 M)

Prenetics Global and related stocks such as Neuronetics, Atlantic International, and MaxCyte Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Prenetics Global financial statement analysis. It represents the amount of money remaining after all of Prenetics Global operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Prenetics Global Competitive Analysis

The better you understand Prenetics Global competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Prenetics Global's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Prenetics Global's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
PRE STIM ATLN MXCT TLSI PROF OSUR IMDX ARMP SGMO
 9.77 
 21.12 
Prenetics
 4.49 
 1.49 
Neuronetics
 6.96 
 3.21 
Atlantic
 1.30 
 0.80 
MaxCyte
 3.76 
 4.69 
TriSalus
 3.23 
 6.71 
Profound
 4.06 
 2.82 
OraSure
 2.46 
 7.14 
Insight
 2.17 
 7.99 
Armata
 14.29 
 0.40 
Sangamo
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Current Asset
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Total Debt
Return On Equity
Return On Asset
Number Of Shares Shorted
Book Value Per Share
Current Liabilities
Total Asset
Debt To Equity
Short Ratio
Target Price
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Earnings To Growth
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Prenetics Global Competition Performance Charts

Five steps to successful analysis of Prenetics Global Competition

Prenetics Global's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Prenetics Global in relation to its competition. Prenetics Global's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Prenetics Global in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Prenetics Global's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Prenetics Global, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Prenetics Global position

In addition to having Prenetics Global in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Treasury ETFs Thematic Idea Now

Treasury ETFs
Treasury ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Treasury ETFs theme has 131 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Treasury ETFs Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Prenetics Global is a strong investment it is important to analyze Prenetics Global's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Prenetics Global's future performance. For an informed investment choice regarding Prenetics Stock, refer to the following important reports:
Check out Prenetics Global Correlation with its peers.
For information on how to trade Prenetics Stock refer to our How to Trade Prenetics Stock guide.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Will Reinsurance sector continue expanding? Could Prenetics diversify its offerings? Factors like these will boost the valuation of Prenetics Global. Anticipated expansion of Prenetics directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Prenetics Global data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(3.59)
Revenue Per Share
5.821
Quarterly Revenue Growth
2.028
Return On Assets
(0.15)
Return On Equity
(0.30)
Understanding Prenetics Global requires distinguishing between market price and book value, where the latter reflects Prenetics's accounting equity. The concept of intrinsic value - what Prenetics Global's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Prenetics Global's price substantially above or below its fundamental value.
It's important to distinguish between Prenetics Global's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Prenetics Global should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Prenetics Global's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.